Araştırma Makalesi
BibTex RIS Kaynak Göster

INVESTIGATION OF PROTECTIVE EFFECTS OF DIFFERENT DOSES OF OMEGA 3 FATTY ACIDS IN EXPERIMENTAL RENAL ISCHEMIA REPERFUSION DAMAGE

Yıl 2021, Cilt: 28 Sayı: 2, 283 - 289, 15.06.2021
https://doi.org/10.17343/sdutfd.891576

Öz

Objective
Ischemia reperfusion (IR) injury is caused by a sudden
and temporary impairment of blood flow to a particular
organ or tissue. Renal IR-induced kidney damage causes
high levels of permanent damage and mortality.
Dietary omega-3 fatty acids have anti-inflammatory and immune-modulating effects and are used as protective
agents.
Materials and Methods
In the study; Protective effects of different doses of
omega-3 fatty acid in ischemia reperfusion injury were
investigated by biochemical and histological analyzes.
40 adult female rats were divided into 5 groups
as sham control, IR, IR+100, IR+400, IR+700 (n:8).
The right kidney was removed by nephrectomy in the
sham control group, and the left kidney was not treated.
For IR injury; the right kidney was removed by
nephrectomy, and the left kidney was clamped. Omega-
3 fatty acids of 100 mg/kg, 400 mg/kg and 700 mg/
kg were administered by gastric gavage to the treatment
groups for 14 days before the surgery and for
15. gastric gavage was administrated in the morning
of the operation.
Results
According these data; with application of omega-3,
histopathological examination results were correlated.
It is found that, histopathological results were
supported by biochemical results. There was a significant
decrease in malondialdehyde (MDA) and myeloperoxidase
(MPO) levels in the treated groups, while
catalase (CAT) and glutathione peroxidase (GSH-Px)
levels were detected to be increased.
Conclusion
It was concluded that administration of omega-3 fatty
acids beforehand in cases that may cause ischemia
and reperfusion damage in the kidney can provide a
protective effect on this tissue.

Destekleyen Kurum

Aydın Adnan Menderes University Scientific Research Projects Unit

Proje Numarası

TPF-16032

Teşekkür

The project was supported by the Scientific Research Projects Unit of Aydın Adnan Menderes University with the number TPF-16032.

Kaynakça

  • 1. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009;130:41-50.
  • 2. Ergün O, Ulman C, Kılıçalp AS. Carnitine as a agent in experimental renal ischemia-reperfusion injury. UroI Res 2001;29:186-9.
  • 3. Guyton AC. The kidneys and body fluids. In: Textbook of Medical Physiology. 9th edition. Philadelphia: WB Saunders Company; 1996. 297–313.
  • 4. Gasanov, F., Aytac, B., & Vuruskan, H. (2011). The effects of tadalafil on renal ischemia reperfusion injury: an experimental study. Bosnian journal of basic medical sciences, 11(3), 158.
  • 5. Malek, M., & Nematbakhsh, M. (2015). Renal ischemia/reperfusion injury; from pathophysiology to treatment. Journal of renal injury prevention, 4(2), 20.
  • 6. Islam CF, Mathie RT, Dinneen MD, Kiely EA, Peters AM, Grace PA. Ischemia–reperfusion injury in the rat kidney the effect of preconditioning. Br J Urol 1997;6:842–7.
  • 7. Calder, P. C., & Yaqoob, P. Understanding omega-3 polyunsaturated fatty acids. Postgraduate medicine, 121(6), 148-157.Calder PC: Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007–1024.
  • 8. Mori TA, Beilin LJ: n-3 Fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001, 12:1211–1217.
  • 9. Alejandro V, Scandling JD, Sibley RK, et al: Mechanisms of filtration failure during postischemic injury of the human kidney. J Clin invest 95: 820-831,1995
  • 10. Simmons MN, Schreiber MJ, Gill IS. Surgical Renal Ischemia: A Contemporary Overview. J Urol. 2008;180(1):19-30.
  • 11. Fouad AA, Al-Mulhim AS, Jresat I, Morsy MA. Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury. J Pharm Pharmacol. 2013;65(2):243- 252.
  • 12. Kocoglu H, Ozturk H, Ozturk H, et al. Effect of dexmedetomidine on ischemiareperfusion injury in rat kidney: A histopathologic study. Ren Fail. 2009;31(1):70-74.
  • 13. Williams P, Lopez H, Britt D, et al. Characterization of Renal Ischemia-Reperfusion Injury in Rats. J Pharmacol Toxicol Methods. 1997;Feb:37(1):1-7
  • 14. Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycysticsize ovaries in healthy adolescents. J Clin Endocrinol Metab, 2006, 91: 3786-3790.
  • 15. Sarsılmaz M, Songur A, Özyurt H, et al. Potential role of dietary ω-3 essential fatty acids on some oxidant/antioxidant parameters in rats’ corpus striatum. Prostagl Leukot Essent Fatty Acids 2003; 69(4): 253-259.
  • 16. Miyasaca CK, Alves de Souza JA, Torres RP, Filho JM, Lajolo FM, Curi R. Effect of the administration of fish oil by gavage on activities of antioxidant enzymes of rat lympohoid organs. Gen Pharmacol 1998; 30 (5): 759-762.
  • 17. Grande JP, Walker HJ, Holub BJ ve ark. Suppressive effects of fish oil on mesengial cell proliferation in vitro and in vivo.Kidney Int 2000;57:1027-1040
  • 18. Slater TF. Free radical mechanisms in tissue injury. J Biochem 1984; 222:1-15.
  • 19. Ozan E. Koyutürk L.Sapmaz T. Böbrek İskemi Reperfüzyon Hasarında Antioksidan Olarak Prostoglandin E1(PGE)Kullnımının İncelenmesi: Fırat Üniversitesi Tıp Fakültesi Histoloji Ve Embriyoloji Anabilimdalı. Fırat Tıp Dergisi 2004;9(3):67-71
  • 20. Ohkawa H, Ohishi N, Tagi K.Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-358.
  • 21. İnal M, Altınışık M, Bilgin MD. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct. 2002 dec; 20(4):291-6.
  • 22. Wall J. Antioxidants In Prevention Of Reperfusion Damage Of Vascular Endothelium. TSMJ May 2000;1:67-70.
  • 23. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest. 1991; 100: 176-181.

DENEYSEL BÖBREK İSKEMİ REPERFÜZYON HASARINDA FARKLI DOZLARDAKİ OMEGA 3 YAĞ ASİTLERİNİN KORUYUCU ETKİLERİNİN ARAŞTIRILMASI

Yıl 2021, Cilt: 28 Sayı: 2, 283 - 289, 15.06.2021
https://doi.org/10.17343/sdutfd.891576

Öz

Amaç
İskemi reperfüzyon (IR) hasarı, belirli bir organa kan
akışının ani ve geçici olarak bozulmasından kaynaklanır.
Renal IR kaynaklı böbrek hasarı, yüksek düzeyde
kalıcı hasar ve mortaliteye neden olur. Diyet ile
alınan omega-3 yağ asitleri, antiinflamatuar ve immün
modüle edici etkilere sahiptir ve koruyucu olarak kullanılmaktadır.
Çalışmada; iskemi reperfüzyon hasarında
omega-3 yağ asidinin farklı dozlarının koruyucu
etkileri biyokimyasal ve histolojik analizler ile incelenmiştir.
Gereç ve Yöntem
40 adet erişkin dişi sıçan Düz kontrol, sham kontrol,
IR, IR+100, IR+400, IR+700 olmak üzere 5 gruba ayrıldı
(n:8). Sham grubunda sağ böbrek nefrektomi ile
alındı, sol böbreğe işlem uygulanmadı. I/R hasarına
maruz kalan sağ böbrek nefrektomi ile alındı, sol böbreklere
ise klemp takıldı. Tedavi gruplarına cerrahi girişimden
önceki 14 gün ve operasyon gününün sabahında
toplam 15 sefer 100 mg/kg, 400 mg/kg ve 700
mg/kg’lık omega-3 yağ asitleri gastrik gavaj ile verildi.
Bulgular
Elde edilen verilere göre; artan dozlardaki omega-3
ile histopatolojik inceleme sonuçları korale şekilde iyileşme
tespit edildi. Histopatolojik sonuçlar, biyokimyasal
sonuçlar ile desteklendi. Malondaildehit (MDA) ve
myeloperoksidaz (MPO) düzeylerinde tedavi uygulanan
gruplarda anlamlı düzeyde azalma saptanırken,
katalaz (CAT) ve glutatyon peroksidaz (GSH-Px) düzeylerinde
artış saptandı.
Sonuç
Sonuç olarak; elde edilen bulgulara göre, böbrekte
iskemi ve reperfüzyon hasarı oluşturma ihtimali olan
vakalarda önceden omega-3 yağ asidi verilmesinin bu
dokuda koruyucu etki sağlayabileceği sonucuna ulaşılmıştır.

Proje Numarası

TPF-16032

Kaynakça

  • 1. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009;130:41-50.
  • 2. Ergün O, Ulman C, Kılıçalp AS. Carnitine as a agent in experimental renal ischemia-reperfusion injury. UroI Res 2001;29:186-9.
  • 3. Guyton AC. The kidneys and body fluids. In: Textbook of Medical Physiology. 9th edition. Philadelphia: WB Saunders Company; 1996. 297–313.
  • 4. Gasanov, F., Aytac, B., & Vuruskan, H. (2011). The effects of tadalafil on renal ischemia reperfusion injury: an experimental study. Bosnian journal of basic medical sciences, 11(3), 158.
  • 5. Malek, M., & Nematbakhsh, M. (2015). Renal ischemia/reperfusion injury; from pathophysiology to treatment. Journal of renal injury prevention, 4(2), 20.
  • 6. Islam CF, Mathie RT, Dinneen MD, Kiely EA, Peters AM, Grace PA. Ischemia–reperfusion injury in the rat kidney the effect of preconditioning. Br J Urol 1997;6:842–7.
  • 7. Calder, P. C., & Yaqoob, P. Understanding omega-3 polyunsaturated fatty acids. Postgraduate medicine, 121(6), 148-157.Calder PC: Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007–1024.
  • 8. Mori TA, Beilin LJ: n-3 Fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001, 12:1211–1217.
  • 9. Alejandro V, Scandling JD, Sibley RK, et al: Mechanisms of filtration failure during postischemic injury of the human kidney. J Clin invest 95: 820-831,1995
  • 10. Simmons MN, Schreiber MJ, Gill IS. Surgical Renal Ischemia: A Contemporary Overview. J Urol. 2008;180(1):19-30.
  • 11. Fouad AA, Al-Mulhim AS, Jresat I, Morsy MA. Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury. J Pharm Pharmacol. 2013;65(2):243- 252.
  • 12. Kocoglu H, Ozturk H, Ozturk H, et al. Effect of dexmedetomidine on ischemiareperfusion injury in rat kidney: A histopathologic study. Ren Fail. 2009;31(1):70-74.
  • 13. Williams P, Lopez H, Britt D, et al. Characterization of Renal Ischemia-Reperfusion Injury in Rats. J Pharmacol Toxicol Methods. 1997;Feb:37(1):1-7
  • 14. Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycysticsize ovaries in healthy adolescents. J Clin Endocrinol Metab, 2006, 91: 3786-3790.
  • 15. Sarsılmaz M, Songur A, Özyurt H, et al. Potential role of dietary ω-3 essential fatty acids on some oxidant/antioxidant parameters in rats’ corpus striatum. Prostagl Leukot Essent Fatty Acids 2003; 69(4): 253-259.
  • 16. Miyasaca CK, Alves de Souza JA, Torres RP, Filho JM, Lajolo FM, Curi R. Effect of the administration of fish oil by gavage on activities of antioxidant enzymes of rat lympohoid organs. Gen Pharmacol 1998; 30 (5): 759-762.
  • 17. Grande JP, Walker HJ, Holub BJ ve ark. Suppressive effects of fish oil on mesengial cell proliferation in vitro and in vivo.Kidney Int 2000;57:1027-1040
  • 18. Slater TF. Free radical mechanisms in tissue injury. J Biochem 1984; 222:1-15.
  • 19. Ozan E. Koyutürk L.Sapmaz T. Böbrek İskemi Reperfüzyon Hasarında Antioksidan Olarak Prostoglandin E1(PGE)Kullnımının İncelenmesi: Fırat Üniversitesi Tıp Fakültesi Histoloji Ve Embriyoloji Anabilimdalı. Fırat Tıp Dergisi 2004;9(3):67-71
  • 20. Ohkawa H, Ohishi N, Tagi K.Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-358.
  • 21. İnal M, Altınışık M, Bilgin MD. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct. 2002 dec; 20(4):291-6.
  • 22. Wall J. Antioxidants In Prevention Of Reperfusion Damage Of Vascular Endothelium. TSMJ May 2000;1:67-70.
  • 23. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest. 1991; 100: 176-181.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Makaleleri
Yazarlar

Ferhat Şirinyıldız 0000-0001-8800-9787

Gökhan Cesur 0000-0002-6943-7521

Proje Numarası TPF-16032
Yayımlanma Tarihi 15 Haziran 2021
Gönderilme Tarihi 5 Mart 2021
Kabul Tarihi 30 Temmuz 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 28 Sayı: 2

Kaynak Göster

Vancouver Şirinyıldız F, Cesur G. INVESTIGATION OF PROTECTIVE EFFECTS OF DIFFERENT DOSES OF OMEGA 3 FATTY ACIDS IN EXPERIMENTAL RENAL ISCHEMIA REPERFUSION DAMAGE. SDÜ Tıp Fak Derg. 2021;28(2):283-9.

                                                                                         14791


Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi/Medical Journal of Süleyman Demirel University is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International.